Arm race between Rift Valley fever virus and host.

Xiao Wang, Yupei Yuan, Yihan Liu, Leiliang Zhang
Author Information
  1. Xiao Wang: Department of Infectious Diseases, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  2. Yupei Yuan: Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  3. Yihan Liu: Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  4. Leiliang Zhang: Department of Infectious Diseases, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Abstract

Rift Valley fever (RVF) is a zoonotic disease caused by Rift Valley fever virus (RVFV), an emerging arbovirus within the family of that has potential to cause severe diseases in both humans and livestock. It increases the incidence of abortion or foetal malformation in ruminants and leads to clinical manifestations like encephalitis or haemorrhagic fever in humans. Upon virus invasion, the innate immune system from the cell or the organism is activated to produce interferon (IFN) and prevent virus proliferation. Meanwhile, RVFV initiates countermeasures to limit antiviral responses at transcriptional and protein levels. RVFV nonstructural proteins (NSs) are the key virulent factors that not only perform immune evasion but also impact the cell replication cycle and has cytopathic effects. In this review, we summarize the innate immunity host cells employ depending on IFN signal transduction pathways, as well as the immune evasion mechanisms developed by RVFV primarily with the inhibitory activity of NSs protein. Clarifying the arms race between host innate immunity and RVFV immune evasion provides new avenues for drug target screening and offers possible solutions to current and future epidemics.

Keywords

References

  1. J Virol. 2013 Apr;87(7):3710-8 [PMID: 23325696]
  2. PLoS Pathog. 2008 Jan;4(1):e13 [PMID: 18225953]
  3. Cell. 2005 Sep 9;122(5):669-82 [PMID: 16125763]
  4. Clin Cancer Res. 2011 May 1;17(9):2619-27 [PMID: 21372217]
  5. Front Immunol. 2019 Jul 17;10:1586 [PMID: 31379819]
  6. Front Cell Infect Microbiol. 2022 Jan 19;11:799024 [PMID: 35127560]
  7. J Virol. 2016 Jul 27;90(16):7084-7097 [PMID: 27226375]
  8. J Virol. 2009 May;83(9):4365-75 [PMID: 19211744]
  9. Open Virol J. 2010 Apr 22;4:8-14 [PMID: 20517489]
  10. Virology. 2014 Jan 20;449:270-86 [PMID: 24418562]
  11. Nat Rev Immunol. 2008 Jul;8(7):559-68 [PMID: 18575461]
  12. Endocrinol Metab (Seoul). 2018 Sep;33(3):318-330 [PMID: 30112869]
  13. J Cell Sci. 2016 Jan 1;129(1):9-16 [PMID: 26729027]
  14. Viruses. 2011 May;3(5):493-519 [PMID: 21666766]
  15. Arch Virol. 2017 Aug;162(8):2505-2538 [PMID: 28434098]
  16. Annu Rev Virol. 2022 Sep 29;9(1):437-450 [PMID: 36173701]
  17. J Virol. 2013 Jan;87(1):676-82 [PMID: 23097454]
  18. FEBS Lett. 2007 May 22;581(11):2089-97 [PMID: 17434167]
  19. MMWR Morb Mortal Wkly Rep. 2000 Dec 1;49(47):1065-6 [PMID: 11186611]
  20. Viruses. 2021 Feb 26;13(3): [PMID: 33652597]
  21. J Virol. 2016 Oct 14;90(21):9683-9692 [PMID: 27535047]
  22. PLoS Pathog. 2012;8(4):e1002661 [PMID: 22532801]
  23. Trop Med Int Health. 2014 Dec;19(12):1420-9 [PMID: 25252137]
  24. J Biol Chem. 2012 Mar 2;287(10):7399-410 [PMID: 22223653]
  25. Pathog Dis. 2014 Jul;71(2):109-20 [PMID: 24449527]
  26. Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):292-9 [PMID: 18268112]
  27. PLoS Pathog. 2016 Feb 02;12(2):e1005437 [PMID: 26837067]
  28. J Virol. 2011 Jul;85(13):6234-43 [PMID: 21543505]
  29. PLoS Negl Trop Dis. 2013 Apr 18;7(4):e2181 [PMID: 23638202]
  30. Cell. 2004 Feb 20;116(4):541-50 [PMID: 14980221]
  31. J Virol. 2014 Mar;88(6):3464-73 [PMID: 24403578]
  32. Antiviral Res. 2012 Sep;95(3):293-310 [PMID: 22710362]
  33. Virol J. 2016 Jul 02;13:118 [PMID: 27368371]
  34. Front Immunol. 2022 Jun 01;13:865797 [PMID: 35720342]
  35. Infect Immun. 2018 Jan 22;86(2): [PMID: 29158431]
  36. Nat Rev Cancer. 2018 Nov;18(11):681-695 [PMID: 30181570]
  37. Nature. 2008 Nov 27;456(7221):470-6 [PMID: 18978772]
  38. Nat Rev Microbiol. 2008 May;6(5):363-74 [PMID: 18414501]
  39. Clin Infect Dis. 2003 Oct 15;37(8):1084-92 [PMID: 14523773]
  40. J Virol. 2006 Aug;80(16):8274-8 [PMID: 16873285]
  41. Front Immunol. 2022 Sep 12;13:1005586 [PMID: 36172361]
  42. Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17686-91 [PMID: 17965237]
  43. J Virol. 2014 Jul;88(14):7987-97 [PMID: 24807708]
  44. J Virol. 2007 Dec;81(24):13335-45 [PMID: 17913816]
  45. Curr Opin Virol. 2018 Dec;33:74-80 [PMID: 30099321]
  46. Emerg Microbes Infect. 2014 Oct;3(10):e71 [PMID: 26038497]
  47. Annu Rev Biochem. 2007;76:51-74 [PMID: 17352659]
  48. J Virol. 2020 Dec 9;95(1): [PMID: 33087469]
  49. PLoS Pathog. 2019 Dec 9;15(12):e1008186 [PMID: 31815967]
  50. Mol Cell Biol. 2015 Oct 12;36(1):13-29 [PMID: 26459757]
  51. PLoS Pathog. 2009 Feb;5(2):e1000287 [PMID: 19197350]
  52. PLoS One. 2016 Oct 3;11(10):e0163863 [PMID: 27695107]
  53. Viruses. 2022 Sep 17;14(9): [PMID: 36146870]
  54. Mol Cell Biol. 2021 Feb 23;41(3):e0054220 [PMID: 33288641]
  55. Cell Mol Life Sci. 2018 Jan;75(2):193-208 [PMID: 28733901]
  56. ACS Infect Dis. 2020 Sep 11;6(9):2490-2501 [PMID: 32687697]
  57. Biochem Soc Trans. 2002 Nov;30(Pt 6):1064-70 [PMID: 12440973]
  58. J Virol. 2014 Mar;88(6):3067-76 [PMID: 24335286]
  59. Immunity. 2006 Sep;25(3):349-60 [PMID: 16979567]
  60. PLoS Pathog. 2022 May 18;18(5):e1010231 [PMID: 35584192]
  61. J Virol. 2008 Nov;82(22):11152-66 [PMID: 18786992]
  62. Int J Mol Sci. 2019 Mar 21;20(6): [PMID: 30901970]
  63. Immunity. 2006 May;24(5):633-42 [PMID: 16713980]
  64. Front Microbiol. 2016 Feb 11;7:139 [PMID: 26904012]
  65. J Virol. 2019 Jun 28;93(14): [PMID: 31043534]
  66. Onderstepoort J Vet Res. 1982 Mar;49(1):11-7 [PMID: 7122060]
  67. Curr Mol Med. 2005 Dec;5(8):827-34 [PMID: 16375716]
  68. J Virol. 2001 Feb;75(3):1371-7 [PMID: 11152510]
  69. Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):189-92 [PMID: 12502788]
  70. ACS Infect Dis. 2022 Aug 12;8(8):1439-1448 [PMID: 35786847]
  71. Mol Neurobiol. 2013 Jun;47(3):1000-10 [PMID: 23329343]
  72. Virol J. 2012 Jul 28;9:139 [PMID: 22838834]
  73. Front Immunol. 2018 Mar 15;9:534 [PMID: 29599781]
  74. Front Immunol. 2017 Dec 11;8:1758 [PMID: 29312301]
  75. J Virol. 2013 May;87(9):4846-60 [PMID: 23408632]
  76. J Neurovirol. 2014 Jun;20(3):199-208 [PMID: 24578033]
  77. PLoS One. 2011;6(5):e20354 [PMID: 21655261]
  78. Cell Biosci. 2021 Dec 25;11(1):220 [PMID: 34953502]
  79. PLoS One. 2019 May 28;14(5):e0217497 [PMID: 31136639]
  80. Cell. 2011 Oct 14;147(2):423-35 [PMID: 22000019]
  81. J Neuropathol Exp Neurol. 2020 Aug 1;79(8):823-842 [PMID: 32647884]
  82. Antiviral Res. 2018 Aug;156:29-37 [PMID: 29857007]
  83. J Virol. 2016 Jun 10;90(13):6140-7 [PMID: 27122577]
  84. Immunity. 2014 Jan 16;40(1):51-65 [PMID: 24374193]
  85. Nat Commun. 2020 May 1;11(1):2130 [PMID: 32358588]
  86. J Virol. 2010 Jan;84(2):928-39 [PMID: 19889787]
  87. J Cell Sci. 2009 Oct 1;122(Pt 19):3441-54 [PMID: 19759284]
  88. Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2169-74 [PMID: 23345430]

MeSH Term

Animals
Humans
Rift Valley fever virus
Rift Valley Fever
Zoonoses
Interferons
Immune Evasion

Chemicals

Interferons

Word Cloud

Created with Highcharts 10.0.0fevervirusRVFVimmuneRiftValleyinnateevasionimmunityhosthumanscellinterferonIFNproteinnonstructuralproteinsNSsraceRVFzoonoticdiseasecausedemergingarboviruswithinfamilypotentialcauseseverediseaseslivestockincreasesincidenceabortionfoetalmalformationruminantsleadsclinicalmanifestationslikeencephalitishaemorrhagicUponinvasionsystemorganismactivatedproducepreventproliferationMeanwhileinitiatescountermeasureslimitantiviralresponsestranscriptionallevelskeyvirulentfactorsperformalsoimpactreplicationcyclecytopathiceffectsreviewsummarizecellsemploydependingsignaltransductionpathwayswellmechanismsdevelopedprimarilyinhibitoryactivityClarifyingarmsprovidesnewavenuesdrugtargetscreeningofferspossiblesolutionscurrentfutureepidemicsArm

Similar Articles

Cited By